For the second time, researchers from the Heinz Maier-Leibnitz Centre (MLZ), the global biopharmaceutical company AstraZeneca and Malmö University collaborated to advance the understanding of mRNA therapeutics. This time, their focus was on a specific protein and the question of what happens to the…
[read more]